Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Santander reportedly submits bid for UK's TSB

(Sharecast News) - Santander is reportedly among bidders that have submitted a binding offer for Britain's TSB.

The offer would value the Sabadell-owned UK bank at more than £2.3bn and the Spanish lender may hold a board meeting as soon as Tuesday to decide on whether to proceed with the sale and then a winning bid, according to a report on Monday.

Santander and Sabadell declined to comment in response to the story by the Reuters news agency citing two unnamed sources. Other potential bidders include Barclays, Bloomberg previously reported, which the UK bank has not commented on.

The move on TSB, which has the seventh largest branch network among UK banks, comes as Sabadell tries to ward off being taken over by rival BBVA.

Sabadell said earlier this month it had received unsolicited interest in TSB, but any talks need permission from its shareholders. The process is further complicated by an impending decision by BBVA on whether to proceed with its offer for Sabadell, after the Spanish government this month limited a full merger for at least three years.

The buyer of TSB would add assets of £46bn, mainly made up of mortgages, and customer deposits of around £35bn.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.